Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

Also called NCT06634121

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
  • LMU Klinikum Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06634121
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06634121. Randomized; no masking; primary purpose treatment. Start 2024-04-01 (actual); primary completion 2027-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
Acronym
LEAFLET I
Condition
Mitral Regurgitation
Condition
Valvular Heart Disease
Condition
Heart Failure
Intervention (Device)
Transcatheter mitral valve edge-to-edge repair (M-TEER)
Lead sponsor
LMU Klinikum (class: other)

Record details

Record id
cardio:ct-nct06634121
Content hash
36d899514f0f0b7cd16a26c9bd2c8a322b2590c7f370008bae4e63c82e3c2265